Publication Information

{'id': 'https://openalex.org/W4360607680', 'doi': 'https://doi.org/10.1097/ju.0000000000003228.11', 'title': 'PD04-11 MCT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE', 'display_name': 'PD04-11 MCT INHIBITION RESENSITIZES ENZALUTAMIDE-RESISTANT PROSTATE CANCER CELLS TO ENZALUTAMIDE', 'publication_year': 2023, 'publication_date': '2023-03-23', 'ids': {'openalex': 'https://openalex.org/W4360607680', 'doi': 'https://doi.org/10.1097/ju.0000000000003228.11'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/ju.0000000000003228.11', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5065411694', 'display_name': 'Sayani Bhattacharjee', 'orcid': 'https://orcid.org/0000-0001-8781-5867'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Sayani Bhattacharjee', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5016869413', 'display_name': 'Rebecca Wynn', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Rebecca Wynn', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5059569200', 'display_name': 'Puneet Sindhwani', 'orcid': 'https://orcid.org/0000-0002-9420-2978'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Puneet Sindhwani', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013540569', 'display_name': 'Firas G. Petros', 'orcid': 'https://orcid.org/0000-0003-3062-0780'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Firas Petros', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5070199787', 'display_name': 'Nagalakshmi Nadiminty', 'orcid': 'https://orcid.org/0000-0003-3408-3206'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Nagalakshmi Nadiminty', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 68}, 'biblio': {'volume': '209', 'issue': 'Supplement 4', 'first_page': None, 'last_page': None}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10543', 'display_name': 'Prostate Cancer Treatment and Research', 'score': 0.9982, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10570', 'display_name': 'Drug Transport and Resistance Mechanisms', 'score': 0.9937, 'subfield': {'id': 'https://openalex.org/subfields/2730', 'display_name': 'Oncology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10631', 'display_name': 'Cancer, Hypoxia, and Metabolism', 'score': 0.9897, 'subfield': {'id': 'https://openalex.org/subfields/1306', 'display_name': 'Cancer Research'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/enzalutamide', 'display_name': 'Enzalutamide', 'score': 0.9787607}], 'concepts': [{'id': 'https://openalex.org/C2776551883', 'wikidata': 'https://www.wikidata.org/wiki/Q1996756', 'display_name': 'Enzalutamide', 'level': 5, 'score': 0.9787607}, {'id': 'https://openalex.org/C2780192828', 'wikidata': 'https://www.wikidata.org/wiki/Q181257', 'display_name': 'Prostate cancer', 'level': 3, 'score': 0.779923}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.70442486}, {'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.61586535}, {'id': 'https://openalex.org/C96232424', 'wikidata': 'https://www.wikidata.org/wiki/Q4118072', 'display_name': 'Cancer cell', 'level': 3, 'score': 0.5009794}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.37213168}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.33209673}, {'id': 'https://openalex.org/C61367390', 'wikidata': 'https://www.wikidata.org/wiki/Q416601', 'display_name': 'Androgen receptor', 'level': 4, 'score': 0.15145457}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1097/ju.0000000000003228.11', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S30525748', 'display_name': 'The Journal of Urology', 'issn_l': '0022-5347', 'issn': ['0022-5347', '1527-3792'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310315671', 'host_organization_name': 'Lippincott Williams & Wilkins', 'host_organization_lineage': ['https://openalex.org/P4310315671', 'https://openalex.org/P4310318547'], 'host_organization_lineage_names': ['Lippincott Williams & Wilkins', 'Wolters Kluwer'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.62, 'id': 'https://metadata.un.org/sdg/3', 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4379983849', 'https://openalex.org/W4361849348', 'https://openalex.org/W4361849260', 'https://openalex.org/W4361823263', 'https://openalex.org/W3155718207', 'https://openalex.org/W3044054345', 'https://openalex.org/W3016632711', 'https://openalex.org/W3013460946', 'https://openalex.org/W2927728931', 'https://openalex.org/W2177175549'], 'abstract_inverted_index': {'You': [0], 'have': [1], 'accessJournal': [2], 'of': [3, 100, 106, 132, 144, 196, 218, 252, 275, 294, 312, 317, 330, 359, 374, 377], 'UrologyCME1': [4], 'Apr': [5], '2023PD04-11': [6], 'MCT': [7, 162, 175, 219, 256, 276, 280, 302, 331, 339, 353], 'INHIBITION': [8], 'RESENSITIZES': [9], 'ENZALUTAMIDE-RESISTANT': [10], 'PROSTATE': [11], 'CANCER': [12], 'CELLS': [13], 'TO': [14], 'ENZALUTAMIDE': [15], 'Sayani': [16, 27, 416], 'Bhattacharjee,': [17], 'Rebecca': [18, 36, 423], 'Wynn,': [19], 'Puneet': [20, 45, 430], 'Sindhwani,': [21], 'Firas': [22, 54, 437], 'Petros,': [23], 'and': [24, 63, 158, 209, 212, 232, 245, 265, 291, 364, 393, 412], 'Nagalakshmi': [25, 64, 444], 'Nadiminty': [26, 66, 445], 'BhattacharjeeSayani': [28], 'Bhattacharjee': [29, 417], 'More': [30, 39, 48, 57, 67, 418, 425, 432, 439, 446], 'articles': [31, 40, 49, 58, 68, 419, 426, 433, 440, 447], 'by': [32, 41, 50, 59, 69, 388, 407, 420, 427, 434, 441, 448], 'this': [33, 42, 51, 60, 70, 421, 428, 435, 442, 449], 'author': [34, 43, 52, 61, 71, 422, 429, 436, 443, 450], ',': [35, 44, 53, 62], 'WynnRebecca': [37], 'Wynn': [38, 424], 'SindhwaniPuneet': [46], 'Sindhwani': [47, 431], 'PetrosFiras': [55], 'Petros': [56, 438], 'NadimintyNagalakshmi': [65], 'View': [72], 'All': [73, 452], 'Author': [74], 'Informationhttps://doi.org/10.1097/JU.0000000000003228.11AboutPDF': [75], 'ToolsAdd': [76], 'to': [77, 124, 129, 146, 155, 183, 346], 'favoritesDownload': [78], 'CitationsTrack': [79], 'CitationsPermissionsReprints': [80], 'ShareFacebookLinked': [81], 'InTwitterEmail': [82], 'Abstract': [83], 'INTRODUCTION': [84], 'AND': [85], 'OBJECTIVE:': [86], 'Prostate': [87, 379, 380], 'cancers': [88], '(PCa)': [89], 'exhibit': [90], 'a': [91, 138, 328, 369], 'unique': [92], 'metabolic': [93, 151, 310], 'profile': [94], 'with': [95, 215, 230, 255, 299, 306, 327, 333], 'reliance': [96], 'on': [97], 'different': [98, 104], 'forms': [99], 'glucose': [101], 'metabolism': [102], 'at': [103], 'stages': [105], 'disease': [107], 'progression.': [108], 'Early': [109], 'stage': [110], 'PCa': [111, 121, 169, 188, 199, 253, 296, 313, 319, 363], 'cells': [112, 122, 214, 254, 297], 'use': [113], 'the': [114, 130, 142, 193, 273, 279, 288, 309, 357], 'more': [115], 'efficient': [116], 'TCA': [117], 'cycle,': [118], 'while': [119], 'metastatic': [120], 'switch': [123], 'glycolysis': [125], '(Warburg': [126], 'effect),': [127], 'leading': [128], 'accumulation': [131], 'lactate.': [133], 'Monocarboxylate': [134], 'transporters': [135], '(MCTs)': [136], 'play': [137], 'major': [139], 'role': [140], 'in': [141, 167, 187, 198, 228, 242, 263, 304, 350, 362], 'export/import': [143], 'lactate': [145], 'maintain': [147], 'redox': [148], 'balance.': [149], 'Such': [150], 'reprogramming': [152], 'can': [153], 'lead': [154], 'gain-of-function': [156], 'mutations': [157], 'affect': [159], 'drug': [160], 'sensitivity.': [161], 'expression': [163, 194], 'levels': [164, 195], 'are': [165], 'high': [166], 'enzalutamide-resistant': [168, 213, 295, 318], 'cells.': [170, 189, 301, 314], 'Hence,': [171], 'we': [172], 'hypothesized': [173], 'that': [174, 272, 338], 'inhibition': [176, 303, 340], 'may': [177, 341, 355, 367], 'be': [178, 342], 'an': [179, 343], 'attractive': [180], 'therapeutic': [181], 'strategy': [182, 345], 'overcome': [184], 'enzalutamide': [185, 231, 259, 307, 348, 360], 'resistance': [186, 349, 361], 'METHODS:': [190], 'We': [191, 206, 248, 270], 'analyzed': [192], 'MCTs': [197], 'tissues': [200], 'using': [201, 278], 'public': [202], 'datasets': [203], 'from': [204], 'Oncomine.': [205], 'treated': [207, 249, 326], 'C4-2B': [208], '22Rv1': [210], 'parental': [211, 300], 'varying': [216], 'concentrations': [217], 'inhibitors': [220, 257, 332], 'AR-C155858,': [221, 282], 'AZD3965,': [222, 283], 'or': [223, 227, 258, 262, 284], 'syrosingopine': [224, 285], 'either': [225, 260], 'singly': [226, 261], 'combination': [229, 264, 305, 329], 'assessed': [233, 266], 'cell': [234, 236, 320], 'survival,': [235, 290], 'viability,': [237], 'proliferation,': [238, 289], 'clonogenic': [239, 292], 'ability,': [240], 'survival': [241], '3-D': [243], 'models,': [244], 'glycolytic': [246], 'activity.': [247], 'mouse': [250], 'xenografts': [251, 321], 'tumor': [267], 'growth.': [268], 'RESULTS:': [269], 'found': [271], 'suppression': [274], 'activity': [277], 'antagonists': [281], 'significantly': [286, 324], 'diminished': [287], 'ability': [293], 'compared': [298], 'inhibited': [308], 'adaptation': [311], 'Tumor': [315], 'growth': [316], 'was': [322], 'suppressed': [323], 'when': [325], 'enzalutamide.': [334], 'These': [335], 'findings': [336], 'imply': [337], 'effective': [344], 'counter': [347], 'PCa.': [351], 'CONCLUSIONS:': [352], 'activation': [354], 'underlie': [356], 'development': [358], 'targeting': [365], 'it': [366], 'represent': [368], 'viable': [370], 'combinatorial': [371], 'option.': [372], 'Source': [373], 'Funding:': [375], 'Department': [376], 'Defense': [378], 'Cancer': [381], 'Research': [382], 'Program': [383], 'W81XWH2010794': [384], '(PC190332)': [385], '©': [386], '2023': [387, 406], 'American': [389, 408], 'Urological': [390, 409], 'Association': [391, 410], 'Education': [392, 411], 'Research,': [394, 413], 'Inc.FiguresReferencesRelatedDetails': [395], 'Volume': [396], '209Issue': [397], 'Supplement': [398], '4April': [399], '2023Page:': [400], 'e146': [401], 'Advertisement': [402, 453], 'Copyright': [403], '&': [404], 'Permissions©': [405], 'Inc.MetricsAuthor': [414], 'Information': [415], 'Expand': [451], 'PDF': [454], 'downloadLoading': [455], '...': [456]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4360607680', 'counts_by_year': [], 'updated_date': '2024-12-09T09:18:11.425168', 'created_date': '2023-03-24'}